Latest News about jnj
Recent news which mentions jnj
It’s OK to Sell the News on Ocugen and Covaxin
September 20, 2021
From InvestorPlace
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
From Benzinga
Got $1,000? Here Are 2 Unstoppable Dividend Stocks to Buy
September 19, 2021
From Motley Fool
Here's Why Moderna's Stock Could Crash Before the End of 2021
September 19, 2021
From Motley Fool
Moderna's Bigger Catalyst: Full FDA Approval or Booster Authorization?
September 19, 2021
From Motley Fool
Could This News Spark a Turnaround for Ocugen?
September 19, 2021
From Motley Fool
FDA committee votes against approving BioNTech and Pfizer’s COVID-19 booster
September 17, 2021
From MarketWatch
3 Value Dividend Stocks for High Total Returns
September 17, 2021
From InvestorPlace
Janssen Shares Erdafitinib Combo Therapy Data In Bladder Cancer
September 17, 2021
Tickers
JNJ
From Benzinga
WHO warns lack of COVID-19 vaccine supply in Africa could make it breeding ground for new variants and ‘send the whole world back to square one’
September 17, 2021
From MarketWatch
BioSig Expands in Electrophysiology with St. Elizabeth's Medical Center Evaluation
September 17, 2021
From Benzinga
Is Moderna Winning on Vaccine Efficacy?
September 17, 2021
From Motley Fool
3 Top Warren Buffett Stocks to Buy and Hold
September 17, 2021
From Motley Fool
HeartFlow: A Deep Dive
September 16, 2021
From Motley Fool
Why Moderna and BioNTech Topped the Market Today
September 16, 2021
From Motley Fool
With the European Union Buying Doses, Novavax Has Plenty of Upside Left
September 16, 2021
From InvestorPlace
U.S. passes grim milestone as 1 in 500 have now died of COVID, and debate about need for boosters heats up
September 16, 2021
From MarketWatch
Scientists continue to say there isn’t enough evidence to support giving COVID-19 boosters to all Americans
September 16, 2021
From MarketWatch
3 Stocks You Can Keep Forever
September 16, 2021
From Motley Fool
7 Great Dividend Stocks To Buy In September For Insulation from Volatility
September 15, 2021
From InvestorPlace
Heart Hope: Announcing the Encouraging Results of a Cell-Therapy Clinical Study by Longeveron
September 15, 2021
From Benzinga
Is AbbVie's 4.9% Dividend Yield Safe?
September 15, 2021
From Motley Fool
Alaska joins Idaho in rationing health care as hospitals are packed with COVID patients, and WHO says Africa is being left behind in vaccine push
September 15, 2021
From MarketWatch
7 Great Stocks to Buy for an Income-Rich Retirement
September 14, 2021
From InvestorPlace
Novavax Has More Room to Run as the Vaccination Push Carries On
September 14, 2021
From InvestorPlace
Can Ketamine For Depression Be Improved? New Study Will Looks Into Ketamine Analog Arketamine
September 14, 2021
From Benzinga
‘Shoulda Got the Shot’: New PSAs employ real people rather than science and data to encourage unvaccinated Americans to change their minds
September 14, 2021
From MarketWatch
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
G Medical Innovations: The Next Generation of Healthcare for Caregivers and Patients
September 13, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.